CD44 is a putative marker of breast cancer stem cells (CSCs) [11], and changes of its expression are implied in the transit between non-stem cancer cells (non-CSCs) and CSCs or shift between epithelial-CSCs and mesenchymal-CSCs [12–14], conferring to the high flexibility of cancer cells. This evidence concerns the gene CD44 and breast cancer.